The average one-year price target for Omeros (NasdaqGM:OMER) has been revised to $34.34 / share. This is an increase of 12.22 ...
H.C. Wainwright raised the firm’s price target on Unicycive Therapeutics (UNCY) to $22 from $9 and keeps a Buy rating on the shares. The believes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback